Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
Clinical trial NCT04023110 · COMPLETED
Trial details
- NCT number
- NCT04023110
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-09
- Primary completion
- 2024-08-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.